Results 141 to 150 of about 90,148 (266)
Abstract Antimicrobial stewardship (AMS) programs were introduced to promote the judicious use of antimicrobials and to combat antimicrobial resistance. Quantifying antibiotic consumption is an important part of AMS initiatives to achieve these objectives.
Marjan Kandimahforoujaki +3 more
wiley +1 more source
Center on Budget Policy and Priorities: A Guide to Budget for NGOs
The Center on Budget and Policy Priorities (CBPP) iz Washingtona, odnosno The International Budget Project (IBP) kao dio tog Centra, objavio je 1999. godine Vodič kroz proračune u praksi za nevladine udruge (A Guide to Budget Work for NGOs) kako bi javnosti i institucijama pomogao u boljem razumijevanju proračunske problematike. Od 1999.
openaire +2 more sources
Costs and Budget Impact of a Health System Strengthening Intervention for Hypertension and Cardiovascular Disease Care in Ghana. [PDF]
Singh K +7 more
europepmc +1 more source
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley +1 more source
Intergenerational Linkages and Government Budget Policies [PDF]
openaire +3 more sources
CP-LDS-MCTS: A Decision-Making Method for Unsignalized Intersections Based on Low-Discrepancy Sampling and Safety Pruning. [PDF]
Sun N, Yu J, Gao Y, Xiao G.
europepmc +1 more source
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley +1 more source
The changing landscape of substance use disorders over 30 years: insights on US state disparities and policy from the global burden of disease study. [PDF]
Bazargan-Hejazi S +6 more
europepmc +1 more source
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source

